VKH
GBT

Virtu KCG Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Virtu KCG Holdings’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$219K Buy
+8,021
New +$239K 0.01% 2072

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Virtu KCG Holdings's GBT Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q2 2017: 8,021 shares worth $219K. The stake represents 0.01% of the portfolio and ranks #2072 among its holdings.

134 funds tracked by Wall St. Rank hold GBT as of Q2 2017.

  • Virtu KCG Holdings held 8,021 shares of Global Blood Therapeutics, Inc. worth $219K as of Q2 2017.
  • Global Blood Therapeutics, Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Global Blood Therapeutics, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2072 holding.
  • 134 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.